Cargando…
A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646118/ http://dx.doi.org/10.1186/2051-1426-3-S2-P117 |
_version_ | 1782400918470262784 |
---|---|
author | Ladd, Alden Lilley, Graham Li, Mingli Cossette, Dan Hopkins, Gregory W Maier, Dawn Paglia, Michael Morgan, Richard A |
author_facet | Ladd, Alden Lilley, Graham Li, Mingli Cossette, Dan Hopkins, Gregory W Maier, Dawn Paglia, Michael Morgan, Richard A |
author_sort | Ladd, Alden |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4646118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46461182015-11-20 A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma Ladd, Alden Lilley, Graham Li, Mingli Cossette, Dan Hopkins, Gregory W Maier, Dawn Paglia, Michael Morgan, Richard A J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4646118/ http://dx.doi.org/10.1186/2051-1426-3-S2-P117 Text en Copyright © 2015 Ladd et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Ladd, Alden Lilley, Graham Li, Mingli Cossette, Dan Hopkins, Gregory W Maier, Dawn Paglia, Michael Morgan, Richard A A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma |
title | A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma |
title_full | A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma |
title_fullStr | A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma |
title_full_unstemmed | A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma |
title_short | A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma |
title_sort | simple and robust clinical manufacturing process for the ex-vivo expansion of autologous t cells genetically engineered to express an anti-bcma chimeric antigen receptor (car) for the treatment of multiple myeloma |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646118/ http://dx.doi.org/10.1186/2051-1426-3-S2-P117 |
work_keys_str_mv | AT laddalden asimpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma AT lilleygraham asimpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma AT limingli asimpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma AT cossettedan asimpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma AT hopkinsgregoryw asimpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma AT maierdawn asimpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma AT pagliamichael asimpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma AT morganricharda asimpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma AT laddalden simpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma AT lilleygraham simpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma AT limingli simpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma AT cossettedan simpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma AT hopkinsgregoryw simpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma AT maierdawn simpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma AT pagliamichael simpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma AT morganricharda simpleandrobustclinicalmanufacturingprocessfortheexvivoexpansionofautologoustcellsgeneticallyengineeredtoexpressanantibcmachimericantigenreceptorcarforthetreatmentofmultiplemyeloma |